PT93137A - Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas - Google Patents

Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas

Info

Publication number
PT93137A
PT93137A PT93137A PT9313790A PT93137A PT 93137 A PT93137 A PT 93137A PT 93137 A PT93137 A PT 93137A PT 9313790 A PT9313790 A PT 9313790A PT 93137 A PT93137 A PT 93137A
Authority
PT
Portugal
Prior art keywords
lower alkyl
group
alkoxy
member selected
carbonyl
Prior art date
Application number
PT93137A
Other languages
English (en)
Other versions
PT93137B (pt
Inventor
Paul L Feldman
Michael K James
Marcus F Brackeen
Michael Ross Johnson
Harry Jefferson Leighton
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of PT93137A publication Critical patent/PT93137A/pt
Publication of PT93137B publication Critical patent/PT93137B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT93137A 1989-02-15 1990-02-14 Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas PT93137B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31131189A 1989-02-15 1989-02-15
US07/448,497 US5019583A (en) 1989-02-15 1989-12-11 N-phenyl-N-(4-piperidinyl)amides useful as analgesics

Publications (2)

Publication Number Publication Date
PT93137A true PT93137A (pt) 1990-08-31
PT93137B PT93137B (pt) 1996-02-29

Family

ID=26977841

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93137A PT93137B (pt) 1989-02-15 1990-02-14 Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas

Country Status (22)

Country Link
US (1) US5019583A (pt)
EP (1) EP0383579B1 (pt)
JP (1) JP2895145B2 (pt)
KR (1) KR0160979B1 (pt)
AT (1) ATE140451T1 (pt)
AU (1) AU636330B2 (pt)
CA (1) CA2010011C (pt)
CY (1) CY2002A (pt)
CZ (1) CZ402591A3 (pt)
DE (2) DE69027794T2 (pt)
DK (1) DK0383579T3 (pt)
ES (1) ES2088961T4 (pt)
GR (1) GR3020719T3 (pt)
HK (1) HK78297A (pt)
IE (1) IE77156B1 (pt)
LU (1) LU90011I2 (pt)
MX (1) MX9203024A (pt)
NL (1) NL960030I2 (pt)
NZ (1) NZ232542A (pt)
PT (1) PT93137B (pt)
SG (1) SG47967A1 (pt)
SK (1) SK402591A3 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130321A (en) * 1990-12-18 1992-07-14 Glaxo Inc. Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides
US5214148A (en) * 1990-12-18 1993-05-25 Glaxo Inc. Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides
GB9316863D0 (en) * 1993-08-13 1993-09-29 Glaxo Group Ltd Chemical process
US5466700A (en) * 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5866591A (en) * 1996-09-11 1999-02-02 Glaxo Wellcome Inc. Stable formulations of remifentanil
ATE306472T1 (de) * 1997-12-24 2005-10-15 Ortho Mcneil Pharm Inc (4)-(aryl(piperidin-4-yl) aminobenzamidderivate die an delta-opioid rezeptor binden
US6858018B1 (en) * 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
US6436959B1 (en) 1998-12-23 2002-08-20 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)]aminobenzamides
US7074935B2 (en) 1999-12-06 2006-07-11 Mallinckrodt Inc. Methods for the syntheses of alfentanil, sufentanil and remifentanil
WO2001068604A2 (en) 2000-03-14 2001-09-20 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
ES2302742T5 (es) * 2000-07-31 2011-10-10 Nycomed Danmark Aps Pulverizador nasal para suministrar una composición farmacéutica.
WO2002096351A2 (en) 2001-04-03 2002-12-05 Aryx Therapeutics Ultrashort-acting opioids for transdermal application
AU2002361709A1 (en) * 2001-12-17 2003-06-30 Aryx Therapeutics Analgesic delivery systems and methods of use
JPWO2005030722A1 (ja) * 2003-09-29 2006-12-07 日本ケミファ株式会社 N−置換−n−(4−ピペリジニル)アミド誘導体
MXPA06013917A (es) 2004-06-18 2007-03-07 Neurosearch As Nuevos derivados de piperidina sustituidos con alquilo y su uso como inhibidores de la recaptacion del neurotransmisor monoamino.
US20090030041A1 (en) * 2004-09-14 2009-01-29 Toshihiro Takahashi N-substituted N-(4-piperidinyl) Amide Derivative
EP1966140A1 (en) * 2005-11-17 2008-09-10 Mallinckrodt, Inc. Process for synthesizing remifentanil
JP2009524659A (ja) * 2006-01-24 2009-07-02 マリンクロッド・インコーポレイテッド レミフェンタニルの合成方法
CN101379032A (zh) * 2006-02-03 2009-03-04 马林克罗特公司 瑞芬太尼盐酸盐的晶型
EP1867635A1 (en) * 2006-06-15 2007-12-19 Kern Pharma, S.L. Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
GB0613693D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
RU2470935C2 (ru) 2006-07-10 2012-12-27 ПАЙОН ЮКей ЛИМИТЕД Бензодиазепиновые соли кратковременного действия и их полиморфные формы
WO2008045192A2 (en) * 2006-10-05 2008-04-17 Mallinckrodt Inc. Alternate process for remifentanil preparation
AU2007325889A1 (en) * 2006-11-29 2008-06-05 Mallinckrodt Inc. New process for remifentanil synthesis
MX2010010675A (es) 2008-03-31 2010-11-25 Gen Hospital Corp Analogos de etomidato con propiedades farmacocineticas y farmacodinamicas mejoradas.
WO2010000282A1 (de) * 2008-07-03 2010-01-07 Cilag Ag Verfahren zur herstellung von n-phenyl-n-(4-piperidinyl) amidsalzen
WO2010053944A1 (en) * 2008-11-04 2010-05-14 Cambrex Charles City, Inc. Improved method of making piperidine derivatives
BR112012000606A2 (pt) 2009-07-10 2016-11-22 Brigham & Womens Hospital análogos de etomidato que não inibem a síntese de esteróides adrenocorticais
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
IN2014DN06132A (pt) 2012-01-13 2015-08-14 Gen Hospital Corp
KR20150065873A (ko) 2012-10-08 2015-06-15 오클랜드 유니서비시즈 리미티드 케타민 유도체
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN103728403B (zh) * 2013-08-30 2015-10-07 宜昌人福药业有限责任公司 一种盐酸瑞芬太尼原料药中有关物质的检测方法
EP3199523B1 (en) 2016-01-29 2018-08-15 Bioka s. r.o. The new process for producing n-phenyl-n-(4-piperidinyl) amide derivatives such as remifentanil and carfentanil
PL3643704T3 (pl) 2018-10-26 2021-06-14 Hameln Pharma Gmbh Nowe produkty pośrednie do wytwarzania chlorowodorku remifentanilu
GB202010168D0 (en) 2020-07-02 2020-08-19 Johnson Matthey Plc Process for preparing remifentanil hydrochloride
CN114262320A (zh) * 2021-12-28 2022-04-01 宜昌人福药业有限责任公司 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284196A (pt) * 1961-10-10
US3655675A (en) * 1968-09-09 1972-04-11 Sterling Drug Inc N-(n-heteryl)-acylanilides
US3998834A (en) * 1975-03-14 1976-12-21 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-n-phenylamides and -carbamates
US4179569A (en) * 1975-03-14 1979-12-18 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-N-phenylamides
US4167574A (en) * 1978-03-13 1979-09-11 Janssen Pharmaceutica, N.V. N-phenyl-N-(4-piperidinyl)amides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
US4801721A (en) * 1984-08-16 1989-01-31 Ryan James W Stereospecific synthesis of carboxyalkyl peptides
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides

Also Published As

Publication number Publication date
GR3020719T3 (en) 1996-11-30
US5019583A (en) 1991-05-28
EP0383579B1 (en) 1996-07-17
CA2010011A1 (en) 1990-08-15
LU90011I2 (fr) 1997-03-11
ATE140451T1 (de) 1996-08-15
ES2088961T4 (es) 1996-12-01
CZ402591A3 (en) 1993-04-14
IE77156B1 (en) 1997-12-03
AU4973190A (en) 1990-08-23
SK402591A3 (en) 2000-09-12
NL960030I2 (nl) 1997-05-01
DE19675028I2 (de) 2002-11-07
ES2088961T3 (es) 1996-10-01
KR0160979B1 (ko) 1998-12-01
HK78297A (en) 1997-06-20
CA2010011C (en) 1997-12-02
AU636330B2 (en) 1993-04-29
MX9203024A (es) 1992-07-01
KR900012906A (ko) 1990-09-03
CY2002A (en) 1997-12-05
DE69027794T2 (de) 1997-01-02
DK0383579T3 (da) 1996-10-14
EP0383579A1 (en) 1990-08-22
SG47967A1 (en) 1998-04-17
IE900532L (en) 1990-08-15
JPH02300167A (ja) 1990-12-12
NL960030I1 (nl) 1997-02-03
NZ232542A (en) 1992-06-25
DE69027794D1 (de) 1996-08-22
JP2895145B2 (ja) 1999-05-24
PT93137B (pt) 1996-02-29

Similar Documents

Publication Publication Date Title
PT93137A (pt) Processo para a preparacao de n-fenil-n-(4-piperidinil) amidas
BR9912494B1 (pt) derivado de di ou trifluorometanossulfonil anilida, processo para a sua produção e herbicida contendo o referido derivado como ingrediente ativo.
DE3562374D1 (en) Compound having antibronchopneumopathic activity, process for its preparation and pharmaceutical compositions containing it
PT94084A (pt) Processo para a preparacao den n-(ariloxialquil)-heteroarilpiperidinas e - heteroarilpiperazinas e de composicoes farmaceuticas que os contem
MX11031A (es) Proceso para la preparacion de nuevas 1-fenil-3-naftaleniloxipropanaminas producto obtenido y composicion farmaceutica que lo incluye.
PT94297A (pt) Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem
PT90725A (pt) Processo para a preparacao de novos compostos cefem
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
HUT57773A (en) Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds
DZ1560A1 (fr) Procédé de préparation, d'un dérivé de benzothiazole, et d'une compostion pharmaceutique le contenant et procédé de traitement en comportant application.
ES2114722T3 (es) Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos.
EP0246507A1 (en) N-cyanoalkylisonicotinamide derivatives
ATE246685T1 (de) Piperidone als tachykinin-hemmer
HUT50352A (en) Process for producing new antiviral prine derivatives and pharmaceutical compositions comprising same
BR9813607A (pt) Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar uma condição de doença
DK0494604T3 (da) 1-Piperazinyl-2-butener og -2-butyner, mellemprodukter derfor, en fremgangsmåde til fremstilling deraf og deres anvendelse
IL99434A0 (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and pharmaceutical compositions containing them
PT911336E (pt) Derivados do acido piridonacarboxilico e intermediarios para a sua sintese
PT96017A (pt) Processo para a preparacao de hexahidro-1h-quino{4,3,2-ef}{1,4}benzoxazeinas e de composicoes farmaceuticas que os contem
GR3005904T3 (pt)
TH20624A (th) อนุพันธ์แอซิลของแอโซโลน

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19951114

PC4A Transfer of assignment

Owner name: GLAXO WELLCOME INC., US

Effective date: 20090624

Owner name: SMITHKLINE BEECHAM CORPORATION, US

Effective date: 20090624

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20101115